SynopsisAlpha-1 antitrypsin deficiency (A1AD) is a hereditary disorder characterized by low levels of a protein called alpha-1 antitrypsin (A1AT) which is found in the blood. This deficiency may predispose an individual to several illnesses and most commonly manifests.....
SynopsisThe global Trigeminal Neuralgia Therapeutics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 20.....
SynopsisThe global Visceral Pain Treatment market was valued at US$ 13430 million in 2023 and is anticipated to reach US$ 19220 million by 2030, witnessing a CAGR of 5.2% during the forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD .....
SynopsisThe global Hodgkin Lymphoma Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, gro.....
SynopsisThe global Burns Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a C.....
SynopsisThe global Ragweed Pollen Allergy Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 202.....
SynopsisThe global Osteomyelitis Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growin.....
SynopsisThe global Osteogenesis Imperfecta Treatment market was valued at US$ 688.1 million in 2023 and is anticipated to reach US$ 769.3 million by 2030, witnessing a CAGR of 1.6% during the forecast period 2024-2030. The global pharmaceutical market is 1475 bi.....
SynopsisThe global Complex Regional Pain Syndrome Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. The global pharmaceutical market is 1475 billion US.....
SynopsisThe global Microscopic Polyangiitis (MPA) Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. The global pharmaceutical market is 1475 billion US.....
